Tag: Dupixent

Sanofi, Regeneron get Dupixent EC approval for eosinophilic esophagitis

Raghuram Kadari- February 1, 2023

French pharmaceutical company Sanofi and Regeneron, an American biotechnology company, have received the approval of the European Commission (EC) to market their Dupixent (dupilumab) injection ... Read More

Dupixent delivers positive results in eosinophilic esophagitis trial

pharmanewsdaily- May 24, 2020

Regeneron Pharmaceuticals and Sanofi said that their co-developed eczema drug Dupixent (dupilumab) has met the co-primary endpoints of Part A of a phase 3 trial ... Read More

Sanofi, Regeneron report Dupixent FDA approval for asthma

pharmanewsdaily- October 21, 2018

Dupixent FDA approval : Dupixent (dupilumab), an eczema drug the co-developed by Sanofi and Regeneron Pharmaceuticals, has been approved by the US Food and Drug Administration ... Read More

Dupixent eczema injection gets FDA approval for atopic dermatitis treatment

pharmanewsdaily- April 2, 2017

Dupixent (dupilumab), the co-developed eczema injection from pharma giants Sanofi and Regeneron Pharmaceuticals, has got the US FDA approval for the treatment of moderate-to-severe atopic ... Read More

Eczema drug Dupixent succeeds in phase 3 atopic dermatitis clinical trial

pharmanewsdaily- March 5, 2017

Atopic dermatitis clinical trial : The jointly developed eczema drug, Dupixent (dupilumab) from Sanofi and Regeneron Pharmaceuticals has met the primary endpoints of a crucial ... Read More